Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever

Keyphrases

• Familial Mediterranean Fever 100%
• Revaccination 100%
• BNT162b2 Vaccine 100%
• Myocarditis 66%
• Systemic Side Effects 66%
• Disease Flare 66%
• Pericarditis 66%
• Vaccine Adverse Events 66%
• COVID-19 Vaccine 66%
• Clinical Trials 33%
• Telephone Interview 33%
• Baseline Characteristics 33%
• New Onset 33%
• Medical Files 33%
• Autoimmune Disease 33%
• Bioelectronic Medicine 33%
• One Dose 33%
• Two-dose 33%
• Vaccine Dose 33%
• Prototypic 33%
• Autoinflammatory Diseases 33%
• Local Reaction 33%
• Autoinflammatory 33%
• Criteria for Diagnosis 33%
• M694V mutation 33%
• BNT162b2 33%
• Real-world Trials 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Familial Mediterranean Fever 100%
• COVID-19 Vaccine 100%
• Messenger RNA 100%
• Side Effect 50%
• Adverse Event 50%
• Myocarditis 50%
• Disease Exacerbation 50%
• Pericarditis 50%
• Clinical Trial 25%
• Autoimmune Disease 25%
• Autoinflammatory Disease 25%
• Diseases 25%

Immunology and Microbiology

• Familial Mediterranean Fever 100%
• COVID-19 100%
• Myocarditis 50%
• Pericarditis 50%
• Autoimmune Disease 25%
• Autoinflammatory Syndromes 25%